The Life Sciences / Health Care Industry
From front-line providers to developers of innovative therapies and all participants in the health care supply chain, we help clients achieve their business goals and overcome challenges in a constantly shifting environment.
Latest Life Sciences / Health Care Insights
We write and speak frequently on regulatory and legal developments affecting the life sciences and health care sectors.
More Insights
CMS Mandates New Standards for COVID-19 Vaccine
11/10/2021   |   by Kimberly Gillespie, Erin Whaley
Health Care M&A Activity Remains Immune to COVID-19
03/04/2021   |   by John Jones, Solomon Hunter
Borrower Beware: First False Claims Act PPP Loan Fraud Settlement Signals More to Come
Anti-Kickback Statute Enforcement Year in Review and Outlook for 2021
A Look Back at COVID-19 Legal Issues - and a Look Ahead
12/23/2020   |   by Troutman Pepper
When the COVID-19 Vaccine Arrives, Will Your Business Be Ready?
Fraud Emerges as Telemedicine Surges: Compliance Guidance for Telemedicine Providers
What Virginia's New COVID-19 Regulations Mean for Health Care Employers
Sanitizing Hand Sanitizer - Managing FDA-Recalled Hand Sanitizer
08/18/2020   |   by Greg Blount, Karlie Webb, Morgan Gerard
It's All Hands on Deck in Prosecuting COVID-19 Fraud
08/03/2020   |   by Allison DeLaurentis, Miranda Hooker
US PTO Initiates Expedited Review Process for COVID-19 Related Trademarks
07/20/2020   |   by Michael Hobbs, Judy O'Grady, Jóna Mays
Health Care Providers Challenge Constitutionality of Michigan Shutdown Orders
CARES Act Reforms Monograph System for Over-the-Counter Drugs
04/28/2020   |   by Mary Margaret Spence, Seth Oltman
Federal Funding Update: PPP Phase 3.5 Passes
New Bill Proposes Amendments to FDCPA and FCRA
04/13/2020   |   by Tim Bado, Ethan Ostroff
Stark Law Waivers During the COVID-19 Pandemic
New York Reduces the Statute of Limitations for Recovery of Medical Debt
N.J. Order Authorizes Commandeering of Medical Resources and Other Property
04/03/2020   |   by Melissa Chuderewicz, Samuel Harrison
Some States Loosen Licensing Requirements for Telehealth Providers During COVID-19 Pandemic
03/31/2020   |   by Sara Richman, Brian Callaway
Key Provisions of the CARES Act for Pharma Innovators
03/30/2020   |   by Robert Schaffer
State Medicaid Waivers Provide Flexibility to Out-of-State Providers Treating COVID-19
03/26/2020   |   by Yale Bohn, Matthew Smith
FDA Issues Guidance On Clinical Trial Conduct During COVID-19
03/23/2020   |   by Judith L. O'Grady, Seth Oltman
HHS Waives HIPAA Sanctions to Facilitate Suppression of Coronavirus
Podcasts & Webinars
The Life Sciences / Health Care Team
Our COVID-19 Response Team includes seasoned life sciences and health care attorneys who are well-equipped to handle the challenges presented by COVID-19. Don’t hesitate to contact any of the leaders listed here, or your regular Troutman Pepper attorney.